Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB/c mice (Q45428083)

14 December 2017

title

Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB/c mice (English)

1 reference

14 December 2017

1 reference

Hovden AO

1

1 reference

14 December 2017

Cox RJ

series ordinal

2

1 reference

14 December 2017

Haaheim LR

series ordinal

3

1 reference

14 December 2017

publication date

1 July 2005

1 reference

Scandinavian Journal of Immunology

14 December 2017

published in

1 reference

14 December 2017

volume

62

1 reference

14 December 2017

issue

1

1 reference

14 December 2017

page(s)

36-44

1 reference

Influenza virus still surprises.

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.2005.01633.X

1918 influenza pandemic caused by highly conserved viruses with two receptor-binding variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.2005.01633.X

The 1918 Spanish influenza: integrating history and biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.2005.01633.X

A Controlled Double-Blind Comparison of Reactogenicity, Immunogenicity, and Protective Efficacy of Whole-Virus and Split-Product Influenza Vaccines in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.2005.01633.X

Developing vaccines against pandemic influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.2005.01633.X

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.2005.01633.X

Confronting the avian influenza threat: vaccine development for a potential pandemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.2005.01633.X

Non-lethal viral challenge of influenza haemagglutinin and nucleoprotein DNA vaccinated mice results in reduced viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.2005.01633.X

An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.2005.01633.X

Evidence from the generation of immunoglobulin G-secreting cells that stochastic mechanisms regulate lymphocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.2005.01633.X

The rise and fall of long-lived humoral immunity: terminal differentiation of plasma cells in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.2005.01633.X

Homing of antibody secreting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.2005.01633.X

The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.2005.01633.X

IgM and IgG Antibody Responses after Immunization of Children with Inactivated Monovalent (A/New Jersey/76) and Bivalent (A/New Jersey/76-A/Victoria/75) Influenza Virus Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.2005.01633.X

Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.2005.01633.X

Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.2005.01633.X

Th2 responses to inactivated influenza virus can Be converted to Th1 responses and facilitate recovery from heterosubtypic virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.2005.01633.X

Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.2005.01633.X

CEL-1000--a peptide with adjuvant activity for Th1 immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.2005.01633.X

Co-immunization with plasmid IL-12 generates a strong T-cell memory response in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.2005.01633.X

Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.2005.01633.X

Evaluation of live and inactivated influenza A virus vaccines in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.2005.01633.X

Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8 cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.2005.01633.X

Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.2005.01633.X

Semliki Forest virus infection is enhanced in Th1-prone SJL mice but not in Th2-prone BALB/c mice during Linomide-induced immunomodulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.2005.01633.X

Immune response to a major Trypanosoma cruzi antigen, cruzipain, is differentially modulated in C57BL/6 and BALB/c mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.2005.01633.X

T helper responses to Japanese encephalitis virus infection are dependent on the route of inoculation and the strain of mouse used

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.2005.01633.X

Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.2005.01633.X

Influenza virosomes enhance class I restricted CTL induction through CD4 T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.2005.01633.X

Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.2005.01633.X

Whole virus influenza vaccine activates dendritic cells (DC) and stimulates cytokine production by peripheral blood mononuclear cells (PBMC) while subunit vaccines support T cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-3083.2005.01633.X

10.1111/J.1365-3083.2005.01633.X

21 January 2018

Identifiers

DOI

1 reference

release_acgrppovgzatpj6fn6gpeaqwc4

14 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/acgrppovgzatpj6fn6gpeaqwc4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference